Millennium Management
GMAB icon

Millennium Management’s Genmab GMAB Stock Holding History

Millennium Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25M Buy
910,604
+118,311
+15% +$3.14M 0.01% 1428
2026
Q1 		$21.3M Buy
792,293
+697,720
+738% +$20.9M 0.01% 1499
2025
Q4 		$2.91M Buy
94,573
+3,660
+4% +$114K ﹤0.01% 3596
2025
Q3 		$2.79M Sell
90,913
-295,383
-76% -$7.2M ﹤0.01% 3732
2025
Q2 		$7.98M Sell
386,296
-482,534
-56% -$9.91M ﹤0.01% 2500
2025
Q1 		$17M Sell
868,830
-58,922
-6% -$1.24M 0.01% 1683
2024
Q4 		$19.4M Buy
927,752
+362,920
+64% +$7.97M 0.01% 1550
2024
Q3 		$13.8M Buy
564,832
+183,837
+48% +$4.91M 0.01% 1900
2024
Q2 		$9.57M Sell
380,995
-92,934
-20% -$2.63M ﹤0.01% 2109
2024
Q1 		$14.2M Sell
473,929
-38,352
-7% -$1.13M 0.01% 1855
2023
Q4 		$16.3M Buy
512,281
+371,068
+263% +$11.7M 0.01% 1713
2023
Q3 		$4.98M Buy
141,213
+133,432
+1,715% +$5.08M ﹤0.01% 2686
2023
Q2 		$296K Sell
7,781
-298,641
-97% -$11.9M ﹤0.01% 4891
2023
Q1 		$11.6M Sell
306,422
-612,986
-67% -$23.6M 0.01% 1811
2022
Q4 		$39M Buy
919,408
+797,770
+656% +$32.9M 0.02% 917
2022
Q3 		$3.91M Buy
+121,638
New +$4.27M ﹤0.01% 3143
2022
Q2 		– Sell
-79,558
Closed -$2.88M – 7157
2022
Q1 		$2.88M Sell
79,558
-69,655
-47% -$2.39M ﹤0.01% 3536
2021
Q4 		$5.9M Buy
149,213
+138,921
+1,350% +$5.79M ﹤0.01% 2722
2021
Q3 		$450K Buy
+10,292
New +$462K ﹤0.01% 5452
2021
Q1 		– Sell
-16,279
Closed -$662K – 6136
2020
Q4 		$662K Sell
16,279
-79,315
-83% -$2.96M ﹤0.01% 3997
2020
Q3 		$3.5M Sell
95,594
-160,506
-63% -$5.8M ﹤0.01% 2149
2020
Q2 		$8.68M Sell
256,100
-140,703
-35% -$3.83M 0.01% 1315
2020
Q1 		$8.41M Buy
396,803
+344,730
+662% +$7.68M 0.02% 970
2019
Q4 		$1.16M Sell
52,073
-260,282
-83% -$5.68M ﹤0.01% 2938
2019
Q3 		$6.33M Buy
+312,355
New +$6.15M 0.01% 1613

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management's GMAB Position: Q2 2026 in Review

Millennium Management increased its Genmab (GMAB) stake by 15% in Q2 2026, buying an estimated $3.14M and bringing the position to 910,604 shares worth $25M. The position accounts for 0.01% of the portfolio, ranked #1428.

Millennium Management first reported a position in GMAB in Q3 2019 and has held it in 25 quarters since. The position peaked at $39M in Q4 2022. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Millennium Management held 910,604 shares of Genmab worth $25M as of Q2 2026.
  • Millennium Management bought 118,311 Genmab shares in Q2 2026, an estimated $3.14M.
  • Genmab made up 0.01% of Millennium Management's portfolio in Q2 2026, its #1428 holding.
  • Millennium Management first reported a position in Genmab in Q3 2019 and has held it in 25 quarters since.
  • Millennium Management's Genmab position peaked at $39M in Q4 2022.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.